RAPP vs TRMB · $532.9M cap vs P/E 26, rev $3.68B
Rapport Therapeutics, Inc. Common Stock (RAPP) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
RAPP does not have a complete income-statement cache yet.
Latest reported TRMB revenue for 2025-01-03 was $3.68B. Net income was $1.50B. Revenue was down 3.0% from 2023-12-29 to 2025-01-03. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
RAPP currently screens at market cap $532.9M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the RAPP and TRMB stock pages for the full models.
Not investment advice.